Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company’s adjusted EPS of

We are flat with a downward bias a half-hour before the market opens this Tuesday, with more earnings results reporting favorable conditions in Q4 but potential resistance in Q1. The Dow is -89 points at this hour,

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.